Company Filing History:
Years Active: 1992
Title: **The Innovative Work of Inventor Thomas J. Smith in Oral Mucositis Treatment**
Introduction
Thomas J. Smith is a distinguished inventor based in Ashland, Virginia, known for his significant contribution to medical advancements. He holds a patent that addresses the critical issue of oral mucositis, particularly in patients undergoing chemotherapy and radiotherapy. His innovative approach focuses on using growth factors to prevent and treat this condition effectively.
Latest Patents
Smith's notable patent, titled "Treatment and Prevention of Oral Mucositis with Growth Factors," presents various methods for preventing and treating oral mucositis induced by chemotherapy or radiotherapy. The patent outlines the administration of effective doses of growth factors, such as TGF-α, either alone or in combination with other growth factors. Specifically, the effective dosages range from about 0.01 to 100 micrograms per dose, with administration recommended 2 to 4 times daily. This innovative treatment has the potential to significantly improve the quality of life for patients undergoing cancer treatment.
Career Highlights
Throughout his career, Thomas J. Smith has made impactful strides in medical research and invention. He has collaborated with notable institutions, contributing to advancements in the healthcare sector. Smith's affiliation with Virginia Commonwealth University has further established him as a key figure in medical innovation, particularly within the academic research landscape.
Collaborations
Smith has worked with various organizations that have bolstered his inventive endeavors. Notably, he has been affiliated with Schering Aktiengesellschaft and Virginia Commonwealth University. Additionally, he has collaborated with Dagne L. Florine, who has been instrumental in the development of his patented methods.
Conclusion
Thomas J. Smith's contributions to the field of medicine, particularly in treating oral mucositis, demonstrate the importance of innovation in enhancing patient care. His pioneering work showcases how targeted treatments, such as those involving growth factors, can lead to significant improvements in the lives of individuals undergoing challenging medical treatments. As research continues to evolve, Smith's innovations may pave the way for further advancements in oncological care.